Related Experiment Video
Updated: May 30, 2025

Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies
Published on: September 27, 2024
Case Report: Novel ADA2 variants cause atypical adenosine deaminase 2 deficiency
Haishao Yu1,2, Shuangzhu Lin3, Lin Li4
1Department of Pediatrics, Yantai Yuhuangding Hospital, Shandong, China.
Insights
This case highlights a rare genetic disorder, deficiency of adenosine deaminase 2 (DADA2), presenting with fever and stroke-like symptoms. Early diagnosis and treatment with etanercept led to significant improvement and prevented further attacks.
Area of Science:
- Genetics
- Immunology
- Neurology
Background:
- Deficiency of adenosine deaminase 2 (DADA2) is a rare genetic autoinflammatory disease.
- It is caused by mutations in the ADA2 gene, leading to reduced ADA2 enzyme activity.
- Clinical manifestations can include fever, vasculitis, and neurological events like stroke.
Observation:
- A 2-year-old girl presented with intermittent fever, left limb weakness, and transient urticaria.
- Brain MRI revealed multiple ischemic lesions, indicating systemic inflammation and vasculitis.
- Genetic analysis identified compound heterozygous variants in the ADA2 gene, including a novel intronic variant (c.1082-7T>A).
Findings:
- The novel intronic variant was confirmed to affect mRNA splicing, causing a frameshift and premature stop codon.
- Enzyme activity assays showed a significant decrease in ADA2 activity.
- The patient was diagnosed with DADA2 based on clinical presentation, genetic, and enzymatic findings.
Implications:
- This case expands the known spectrum of ADA2 gene variants associated with DADA2.
- It underscores the importance of genetic and enzymatic testing for diagnosing DADA2, especially in atypical presentations.
- Treatment with etanercept demonstrated efficacy in managing DADA2 symptoms, preventing recurrent neurological events and fever.
Case Presentation:
A girl aged 2 years and 5 months presented to the hospital with chief complaints of intermittent fever and weakness of the left limb for more than 1 month. The child had transient urticaria appearing on her face for 5 days. The inflammatory biomarkers were significantly increased. Brain MRI showed multiple ischemic lesions in the brain's small vessels. The patient exhibited significant systemic inflammation and multiple vasculitis. Whole-exome sequencing showed c.1358A>G p. (Tyr453Cys) and c.1082-7T>A compound heterozygous variants in the adenosine deaminase 2 (ADA2) gene, of which the c.1082-7T>A variant has not been reported yet in previous literature. Peripheral blood mRNA reverse transcription-Sanger sequencing confirmed that this variant affected mRNA splicing, resulting in a frameshift with premature stop codon c.1083_1103del p. (Leu362Glnfs*45). Peripheral blood test suggested a significant decrease in ADA2 activity. Eventually, the patient was diagnosed with deficiency of adenosine deaminase 2 (DADA2). Her condition improved after treatment with etanercept. She had no more fevers, and no hemiplegia attacks were observed during the 3 years of follow-up.
Conclusion:
Fever and hemiplegia were the main manifestations in this patient, without typical rashes. DADA2 was finally confirmed by enzymology and genetic testing, and we believe this is the first reported case of the c.1082-7T>A intronic variant in DADA2, and the RNA studies conducted in this case have been pivotal in assessing its pathogenicity.
More Related Videos
Related Concept Videos
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
RNA Editing
Incomplete Dominance
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Inborn Errors of Metabolism
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

